Noticias/Reuters/EMA committee recommends approval for injectable version of Merck's KeytrudaEMA committee recommends approval for injectable version of Merck's KeytrudaRefinitivMenos de 1 minuto de lecturaMRKMerck MRK said on Friday the European Medicines Agency's committee has recommended the approval for a new formulation of its MRK blockbuster cancer therapy Keytruda that can be administered under the skin.Acciones estadounidensesReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlMostrar másInicie sesión o cree una cuenta gratuita y permanente para leer esta noticia¡Vamos allá!
